Not applicableActive Not RecruitingNCT07286552What this trial is testingBreathing Pattern Description in Pneumonia PatientsWho this might be right forAcute Respiratory Failure (ARF) Consorci Sanitari Integral 82
Early research (Phase 1)Study completedNCT05220605What this trial is testingNebulised BromAc in Healthy VolunteersWho this might be right forCOVID-19 PneumoniaBromelains Adverse ReactionAcetylcysteine Adverse Reaction+2 more Mucpharm Pty Ltd 12
Not applicableStudy completedNCT05256316What this trial is testingRisks of Bacterial and Fungal Superinfection in Patients With COVID-19Who this might be right forCOVID-19 The University of Queensland 790
Large-scale testing (Phase 3)Study completedNCT01561794What this trial is testingA Phase III Study to Evaluate the Safety, Efficacy and Pharmacokinetics/Pharmacodynamics of BAYQ3939 in Patients With Bacterial PneumoniaWho this might be right forPneumonia Bayer 44
Large-scale testing (Phase 3)Study completedNCT00000727What this trial is testingA Controlled Comparative Trial of Sulfamethoxazole-Trimethoprim Versus Aerosolized Pentamidine for Secondary Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients Receiving Azidothymidine (AZT)Who this might be right forPneumonia, Pneumocystis CariniiHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 322
Not applicableUnknownNCT05256511What this trial is testingCOVID-19 and VA-LRTI: Second Versus First Wave of the PandemicWho this might be right forSevere COVID-19 University Hospital, Lille 1,136
Testing effectiveness (Phase 2)UnknownNCT05258682What this trial is testingSafety of Nebulized Combination Therapy BromAc® in COVID-19 Respiratory DiseaseWho this might be right forCOVID-19 PneumoniaCOVID-19Ventilator Associated Pneumonia+1 more Mucpharm Pty Ltd 30
Testing effectiveness (Phase 2)Study completedNCT05175833What this trial is testingOral Probiotics and Secondary Bacterial Pneumonia in Severe COVID-19Who this might be right forCOVID-19 Lower Respiratory InfectionMicrobial ColonizationSevere COVID-19+1 more Universidade de Passo Fundo 70
Post-approval studies (Phase 4)Not Yet RecruitingNCT07357103What this trial is testingPositioning Second-line Therapies for Pneumocystis Jirovecii Pneumonia (PCP Alternatives)Who this might be right forPneumocystisPneumocystis InfectionPneumocystis Carinii Infection+5 more McGill University Health Centre/Research Institute of the McGill University Health Centre 416
Large-scale testing (Phase 3)Study completedNCT00370227What this trial is testingSafety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate VaccineWho this might be right forInfections, Streptococcal GlaxoSmithKline 390
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07431307What this trial is testingSafety, Pharmacokinetics and Efficacy of BV100 Plus Low Dose Polymyxin B Plus Ceftazidime/Avibactam, or Plus Cefiderocol in Patients With Pulmonary and Extrapulmonary Infections Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus ComplexWho this might be right forVentilator Associated Bacterial Pneumonia (VABP)Hospital Acquired Bacterial Pneumonia (HABP)Blood Stream Infection+2 more BioVersys AG